Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2026 to 31 May 2026 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)
Date: 2026-06-30
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: EU Member State, drug surveillance, market approval, marketing standard, medicinal product, veterinary medicinal product, withdrawal from the market








C_202603327EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2026/3327


30.6.2026






Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2026 to 31 May 2026
         


(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
                (1)
or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council
                (2)
)


(C/2026/3327)







—



Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted













Date of the decision


Name of the medicinal product


INN (International Non-Proprietary Name)


Holder of the marketing authorisation


Number of the entry in the Community Register


Pharmaceutical form


ATC code (Anatomical Therapeutic Chemical Code)


Date of notification




6.5.2026


Bysumlog


Insulin lispro







Gan & Lee Pharmaceuticals Europe GmbH




Prinzenallee 11a, 40549 Düsseldorf, Deutschland






EU/1/26/2030


Solution for injection


A10AB04


7.5.2026




21.5.2026


Joenja


leniolisib







Pharming Technologies B.V.




Darwinweg 24, 2333 CR Leiden, Nederland






EU/1/26/2034


Film-coated tablet


L03AX22


22.5.2026




28.5.2026


ADSTILADRIN


nadofaragene firadenovec







Ferring Pharmaceuticals A/S




Amager Strandvej 405, 2770 Kastrup, Danmark






EU/1/26/2035


Concentrate for intravesical suspension


L01XL10


2.6.2026




29.5.2026


Bopediat


furosemide







Proveca Pharma Limited




2 Dublin Landings, North Wall Quay, Dublin 1, D01 V4A3, Ireland






EU/1/26/2027


Orodispersible tablet


C03CA01


1.6.2026




29.5.2026


IMDYLLTRA


tarlatamab







Amgen Europe B.V.




Minervum 7061, 4817 ZK Breda, Nederland






EU/1/26/2033


Powder for concentrate and solution for solution for infusion


L01FX33


1.6.2026




29.5.2026


ZEPZELCA


lurbinectedin







Pharma Mar S.A.




Avenida de los Reyes 1, Polígono Industrial La Mina, 28770 Colmenar Viejo, Madrid, España






EU/1/26/2032


Powder for concentrate for solution for infusion


L01XX69


1.6.2026














—



Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted










Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




4.5.2026


Abiraterone Mylan







Mylan Pharmaceuticals Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/21/1571


8.5.2026




4.5.2026


Circadin







RAD Neurim Pharmaceuticals EEC SARL




4 rue de Marivaux, 75002 Paris, France






EU/1/07/392


7.5.2026




4.5.2026


Clopidogrel/Acetylsalicylic acid Viatris







Viatris Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/19/1395


5.5.2026




4.5.2026


Entyvio







Takeda Pharma A/S




Delta Park 45, 2665 Vallensbaek Strand, Danmark






EU/1/14/923


5.5.2026




4.5.2026


Epysqli







Samsung Bioepis NL B.V.




Olof Palmestraat 10, 2616 LR Delft, Nederland






EU/1/23/1735


8.5.2026




4.5.2026


KAVIGALE







AstraZeneca AB




151 85 Södertälje, Sverige






EU/1/24/1900


5.5.2026




4.5.2026


Kisplyx







Eisai GmbH




Edmund-Rumpler-Strasse 3, 60549 Frankfurt am Main, Deutschland






EU/1/16/1128


5.5.2026




4.5.2026


Movymia







STADA Arzneimittel AG




Stadastraße 2-18, 61118 Bad Vilbel, Deutschland






EU/1/16/1161


5.5.2026




4.5.2026


Pyzchiva







Samsung Bioepis NL B.V.




Olof Palmestraat 10, 2616 LR Delft, Nederland






EU/1/24/1801


6.5.2026




4.5.2026


Stivarga







Bayer AG




D-51368 Leverkusen, Deutschland






EU/1/13/858


11.5.2026




4.5.2026


Tecartus







Kite Pharma EU B.V.




Tufsteen 1, 2132 NT Hoofddorp, Nederland






EU/1/20/1492


12.5.2026




4.5.2026


Tuznue







Prestige Biopharma Belgium BVBA




Terhulpensesteenweg 449, 3090 Overijse, België






EU/1/24/1864


5.5.2026




4.5.2026


Velsipity







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/23/1790


5.5.2026




4.5.2026


Zubsolv







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España






EU/1/17/1233


5.5.2026




6.5.2026


Besponsa







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/17/1200


7.5.2026




6.5.2026


Kymriah







Novartis Europharm Limited




Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland






EU/1/18/1297


7.5.2026




6.5.2026


Veklury







Gilead Sciences Ireland UC




Carrigtohill, County Cork, T45 DP77, Ireland






EU/1/20/1459


7.5.2026




11.5.2026


Azilect







Teva B.V.




Swensweg 5, 2031 GA Haarlem, Nederland






EU/1/04/304


12.5.2026




11.5.2026


Docetaxel Accord







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/12/769


12.5.2026




11.5.2026


Efmody







Immedica Pharma AB




SE-113 63, Stockholm, Sverige






EU/1/21/1549


12.5.2026




11.5.2026


Epruvy







Midas Pharma GmbH




Rheinstraße 49, D-55218 Ingelheim, Deutschland






EU/1/24/1860


13.5.2026




11.5.2026


Hympavzi







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/24/1874


12.5.2026




11.5.2026


Lenvima







Eisai GmbH




Edmund-Rumpler-Strasse 3, 60549 Frankfurt am Main, Deutschland






EU/1/15/1002


12.5.2026




11.5.2026


Levetiracetam SUN







Sun Pharmaceutical Industries Europe BV




Polarisavenue 87, 2132 JH Hoofddorp, Nederland






EU/1/11/741


14.5.2026




11.5.2026


Pazenir







ratiopharm GmbH




Graf-Arco-Straße 3, 89079 Ulm, Deutschland






EU/1/18/1317


13.5.2026




11.5.2026


Piasky







Roche Registration GmbH




Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland






EU/1/24/1848


12.5.2026




11.5.2026


Pluvicto







Novartis Europharm Limited




Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland






EU/1/22/1703


12.5.2026




11.5.2026


Ruxience







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/20/1431


12.5.2026




11.5.2026


Simulect







Novartis Europharm Limited




Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland






EU/1/98/084


12.5.2026




11.5.2026


Sitagliptin/Metformin hydrochloride SUN







Sun Pharmaceutical Industries Europe B.V.




Polarisavenue 87, 2132JH Hoofddorp, Nederland






EU/1/23/1720


22.5.2026




11.5.2026


Tolura







KRKA d d., Novo mesto




Šmarješka cesta 6, 8501 Novo mesto, Slovenija






EU/1/10/632


12.5.2026




11.5.2026


Vevizye







Laboratoires Thea




12 Rue Louis Bleriot, 63100 Clermont-Ferrand, France






EU/1/24/1857


12.5.2026




13.5.2026


Ebymect







AstraZeneca AB




151 85 Södertälje, Sverige






EU/1/15/1051


13.5.2026




13.5.2026


Matever







Pharmathen S.A.




6 Dervenakion, 15351 Pallini Attiki, Ελλάδα






EU/1/11/711


18.5.2026




13.5.2026


Obodence







Samsung Bioepis NL B.V.




Olof Palmestraat 10, 2616 LR Delft, Nederland






EU/1/24/1890


18.5.2026




13.5.2026


Opuviz







Samsung Bioepis NL B.V.




Olof Palmestraat 10, 2616 LR Delft, Nederland






EU/1/24/1865


14.5.2026




13.5.2026


Pregabalin Viatris Pharma







Viatris Healthcare Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland






EU/1/14/916


13.5.2026




13.5.2026


Rytelo







Geron Netherlands B.V.




La Guardiaweg 58, 1043 DJ Amsterdam, Nederland






EU/1/24/1894


26.5.2026




13.5.2026


Tarceva







CHEPLAPHARM Registration GmbH




Weiler Straße 5e, 79540 Lörrach, Deutschland






EU/1/05/311


13.5.2026




13.5.2026


Upstaza







PTC Therapeutics International Limited




70 Sir John Rogerson's Quay, Dublin 2, Ireland






EU/1/22/1653


18.5.2026




21.5.2026


ALTUVOCT







Swedish Orphan Biovitrum AB (publ)




112 76 Stockholm, Sverige






EU/1/24/1824


27.5.2026




21.5.2026


Caprelsa







Esteve Pharmaceuticals S.A.




Passeig de La Zona Franca 109 Planta 4, 08038 Barcelona, España






EU/1/11/749


22.5.2026




21.5.2026


Duloxetine Zentiva







Zentiva, k.s.




U Kabelovny 130, 102 37 Praha 10, Česká republika






EU/1/15/1028


22.5.2026




21.5.2026


DUVYZAT







Italfarmaco S.p.A.




Viale F. Testi, 330, 20126 Milano, Italia






EU/1/25/1930


22.5.2026




21.5.2026


Eltrombopag Accord







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/24/1903


22.5.2026




21.5.2026


Eltrombopag Viatris







Viatris Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland






EU/1/24/1869


25.5.2026




21.5.2026


Evra







Gedeon Richter Plc.




Gyömrői út 19-21, 1103 Budapest, Magyarország






EU/1/02/223


29.5.2026




21.5.2026


Fingolimod Mylan







Mylan Pharmaceuticals Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/21/1573


25.5.2026




21.5.2026


Fycompa







Eisai GmbH




Edmund-Rumpler-Strasse 3, 60549 Frankfurt am Main, Deutschland






EU/1/12/776


22.5.2026




21.5.2026


Ilumetri







Almirall, S.A.




Ronda General Mitre, 151, 08022 Barcelona, España






EU/1/18/1323


27.5.2026




21.5.2026


Inflectra







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/13/854


22.5.2026




21.5.2026


KANJINTI







Amgen Europe B.V.




Minervum 7061, 4817 ZK Breda, Nederland






EU/1/18/1281


26.5.2026




21.5.2026


LIVTENCITY







Takeda Pharmaceuticals International AG Ireland Branch




Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland






EU/1/22/1672


22.5.2026




21.5.2026


Lunsumio







Roche Registration GmbH




Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland






EU/1/22/1649


22.5.2026




21.5.2026


Lytgobi







Taiho Pharma Netherlands B.V.




Barbara Strozzilaan 201, 1083 HN Amsterdam, Noord-Holland, Nederland






EU/1/23/1741


28.5.2026




21.5.2026


PAVBLU







Amgen Technology (Ireland) UC




Pottery Road, Dun Laoghaire, Co. Dublin, A96 F2A8, Ireland






EU/1/25/1909


25.5.2026




21.5.2026


Pelgraz







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/18/1313


22.5.2026




21.5.2026


Pemetrexed Pfizer







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/15/1057


22.5.2026




21.5.2026


Pyrukynd







Agios Netherlands B.V.




Zuidplein 36, Regus Amsterdam WTC, 1077XV Amsterdam, Nederland






EU/1/22/1662


22.5.2026




21.5.2026


Somavert







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/02/240


22.5.2026




21.5.2026


Talzenna







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/19/1377


22.5.2026




21.5.2026


TECVAYLI







Janssen-Cilag International NV




Turnhoutseweg 30, 2340 Beerse, België






EU/1/22/1675


22.5.2026




21.5.2026


Valdoxan







Les Laboratoires Servier




50 rue Carnot, 92284 Suresnes CEDEX, France






EU/1/08/499


22.5.2026




21.5.2026


Yesintek







Biosimilar Collaborations Ireland Limited




Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, D13 R20R, DUBLIN, Ireland






EU/1/24/1892


25.5.2026




26.5.2026


Atazanavir Viatris







Viatris Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/16/1091


27.5.2026




26.5.2026


Byooviz







Samsung Bioepis NL B.V.




Olof Palmestraat 10, 2616 LR Delft, Nederland






EU/1/21/1572


28.5.2026




26.5.2026


Calquence







AstraZeneca AB




151 85 Södertälje, Sverige






EU/1/20/1479


27.5.2026




26.5.2026


Cometriq







Ipsen Pharma




70 rue Balard, 75015 Paris, France






EU/1/13/890


28.5.2026




26.5.2026


Comirnaty







BioNTech Manufacturing GmbH




An der Goldgrube 12, 55131 Mainz, Deutschland






EU/1/20/1528


27.5.2026




26.5.2026


Feraccru







Norgine B.V.




Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland






EU/1/15/1075


27.5.2026




26.5.2026


Galvus







Novartis Europharm Limited




Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland






EU/1/07/414


27.5.2026




26.5.2026


Iasibon







Pharmathen S.A.




6 Dervenakion, 15351 Pallini Attiki, Ελλάδα






EU/1/10/659


28.5.2026




26.5.2026


Jalra







Novartis Europharm Limited




Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland






EU/1/08/485


27.5.2026




26.5.2026


KIMMTRAK







Immunocore Ireland Limited




Unit 1 Sky Business Centres, Unit 21 Block Port Tunnel Business Park, Clonshaugh, Dublin 17, Dublin, D17 FY82, Ireland






EU/1/22/1630


27.5.2026




26.5.2026


Mabthera







Roche Registration GmbH




Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland






EU/1/98/067


27.5.2026




26.5.2026


Memantine Merz







Merz Pharmaceuticals GmbH




Eckenheimer Landstraße 100 D-60318 Frankfurt am Main, Deutschland






EU/1/12/799


9.6.2026




26.5.2026


PREVYMIS







Merck Sharp & Dohme B.V.




Waarderweg 39, 2031 BN Haarlem, Nederland






EU/1/17/1245


27.5.2026




26.5.2026


Privigen







CSL Behring GmbH




Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland






EU/1/08/446


28.5.2026




26.5.2026


Qdenga







Takeda Pharmaceuticals International AG




Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, Co. Dublin, D02 HW68, Ireland






EU/1/22/1699


28.5.2026




26.5.2026


Tigecycline Accord







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/19/1394


27.5.2026




26.5.2026


Truxima







Celltrion Healthcare Hungary Kft.




Váci út 1-3. WestEnd Office Building B torony, 1062 Budapest, Magyarország






EU/1/16/1167


3.6.2026




26.5.2026


Venclyxto







AbbVie Deutschland GmbH & Co. KG




Knollstrasse, 67061 Ludwigshafen, Deutschland






EU/1/16/1138


27.5.2026




26.5.2026


Xiliarx







Novartis Europharm Limited




Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland






EU/1/08/486


27.5.2026




28.5.2026


CARVYKTI







Janssen-Cilag International NV




Turnhoutseweg 30, 2340 Beerse, België






EU/1/22/1648


29.5.2026




28.5.2026


Kapruvia







Vifor Fresenius Medical Care Renal Pharma France




100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France






EU/1/22/1643


29.5.2026




28.5.2026


Namuscla







Lupin Europe GmbH




Hanauer Landstraße 139-143, 60314 Frankfurt am Main, Deutschland






EU/1/18/1325


29.5.2026




28.5.2026


Nemluvio







Galderma International




La Defense 4, Tour Europlaza, 20 Avenue Andre Prothin, 92927 Paris La Defense Cedex, France






EU/1/24/1901


29.5.2026




28.5.2026


OPDIVO







Bristol-Myers Squibb Pharma EEIG




Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland






EU/1/15/1014


29.5.2026




28.5.2026


TachoSil







Corza Medical GmbH




Speditionstraße 21, 40221 Düsseldorf, Deutschland






EU/1/04/277


29.5.2026




29.5.2026


AGAMREE







Santhera Pharmaceuticals (Deutschland) GmbH




Marie-Curie Straße 8, 79539 Lörrach, Deutschland






EU/1/23/1776


3.6.2026




29.5.2026


AQUIPTA







AbbVie Deutschland GmbH & Co. KG




Knollstrasse, 67061 Ludwigshafen, Deutschland






EU/1/23/1750


1.6.2026




29.5.2026


CRYSVITA







Kyowa Kirin Holdings B.V.




Bloemlaan 2, 2132 NP Hoofddorp, Nederland






EU/1/17/1262


2.6.2026




29.5.2026


Dabigatran etexilate Teva







Teva GmbH




Graf-Arco-Straße 3, 89079 Ulm, Deutschland






EU/1/23/1769


1.6.2026




29.5.2026


Ifirmasta







KRKA d d., Novo mesto




Šmarješka cesta 6, 8501 Novo mesto, Slovenija






EU/1/08/480


1.6.2026




29.5.2026


Irbesartan HCT Zentiva







Zentiva k.s.




U kabelovny 130, 102 37 Praha 10, Česká republika






EU/1/06/377


2.6.2026




29.5.2026


Levetiracetam ratiopharm







ratiopharm GmbH




Graf-Arco-Straße 3, 89079 Ulm, Deutschland






EU/1/11/702


2.6.2026




29.5.2026


Levetiracetam Teva







Teva B.V.




Swensweg 5, 2031 GA Haarlem, Nederland






EU/1/11/701


1.6.2026




29.5.2026


Lopinavir/Ritonavir Viatris







Viatris Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/15/1067


2.6.2026




29.5.2026


LysaKare







Novartis Europharm Limited




Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland






EU/1/19/1381


3.6.2026




29.5.2026


Synjardy







Boehringer Ingelheim International GmbH




Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland






EU/1/15/1003


8.6.2026




29.5.2026


Tecovirimat SIGA







SIGA Technologies Netherlands B.V.




Prinsenhil 29, Breda 4825 AX, Nederland






EU/1/21/1600


2.6.2026














—



Withdrawal of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)









Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




4.5.2026


Pritor







Bayer AG




D-51368 Leverkusen, Deutschland






EU/1/98/089


11.5.2026




13.5.2026


Natpar







Takeda Pharmaceuticals International AG Ireland Branch




Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland






EU/1/15/1078


13.5.2026




21.5.2026


Inflectra







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/13/854


22.5.2026














—



Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council; Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council): Accepted










Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




6.5.2026


DIVENCE Tetra







Laboratorios Hipra, S.A.




Avda. La Selva, 135, 17170 Amer (Girona), España






EU/2/24/310


7.5.2026




18.5.2026


PREVEXXION RN







Boehringer Ingelheim Vetmedica GmbH




D-55216 Ingelheim am Rhein, Deutschland






EU/2/20/254


19.5.2026




18.5.2026


PREVEXXION RN+HVT







Boehringer Ingelheim Vetmedica GmbH




D-55216 Ingelheim am Rhein, Deutschland






EU/2/23/302


19.5.2026




18.5.2026


PREVEXXION RN+HVT+IBD







Boehringer Ingelheim Vetmedica GmbH




D-55216 Ingelheim am Rhein, Deutschland






EU/2/20/255


26.5.2026




18.5.2026


Vaxxitek HVT + IBD







Boehringer Ingelheim Vetmedica GmbH




D-55216 Ingelheim am Rhein, Deutschland






EU/2/02/032


19.5.2026




18.5.2026


Vectormune HVT-AIV







Ceva Santé Animale




8 rue de Logrono, 33500 Libourne, France






EU/2/25/335


21.5.2026








Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:





European Medicines Agency




Domenico Scarlattilaan 6




1083 HS Amsterdam




NETHERLANDS






(1)  
            OJ L 136, 30.4.2004, p. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj.

(2)  
            OJ L 4, 7.1.2019, p. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj.


ELI: http://data.europa.eu/eli/C/2026/3327/oj
ISSN 1977-091X (electronic edition)